These results, together with a former report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 aid the thought of focusing on ACKR3 as a novel approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-related Diseases. Conolidine CONOCB2™ fundamentally is https://agnesr714qww4.wikiexcerpt.com/user